JP2011513728A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513728A5 JP2011513728A5 JP2010548752A JP2010548752A JP2011513728A5 JP 2011513728 A5 JP2011513728 A5 JP 2011513728A5 JP 2010548752 A JP2010548752 A JP 2010548752A JP 2010548752 A JP2010548752 A JP 2010548752A JP 2011513728 A5 JP2011513728 A5 JP 2011513728A5
- Authority
- JP
- Japan
- Prior art keywords
- spectrum
- ranges
- patient
- mass spectrum
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/321,393 | 2009-01-20 | ||
| US12/321,393 US7867775B2 (en) | 2006-03-31 | 2009-01-20 | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
| PCT/US2009/006269 WO2010085235A1 (en) | 2009-01-20 | 2009-11-20 | Selection of head and neck cancer patients for treatment with drugs targeting egfr pathway |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011513728A JP2011513728A (ja) | 2011-04-28 |
| JP2011513728A5 true JP2011513728A5 (enExample) | 2012-03-01 |
| JP5025802B2 JP5025802B2 (ja) | 2012-09-12 |
Family
ID=41559566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010548752A Expired - Fee Related JP5025802B2 (ja) | 2009-01-20 | 2009-11-20 | Ｅｇｆｒ経路を標的化する薬物による治療のための頭頸部癌患者の選択 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7867775B2 (enExample) |
| EP (1) | EP2247954B1 (enExample) |
| JP (1) | JP5025802B2 (enExample) |
| KR (1) | KR101131309B1 (enExample) |
| AT (1) | ATE516503T1 (enExample) |
| AU (1) | AU2009338174B2 (enExample) |
| CA (1) | CA2718113A1 (enExample) |
| ES (1) | ES2368784T3 (enExample) |
| IL (1) | IL211943A (enExample) |
| TW (1) | TWI368737B (enExample) |
| WO (1) | WO2010085235A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906342B2 (en) * | 2006-03-31 | 2011-03-15 | Biodesix, Inc. | Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples |
| US7736905B2 (en) | 2006-03-31 | 2010-06-15 | Biodesix, Inc. | Method and system for determining whether a drug will be effective on a patient with a disease |
| US7867775B2 (en) * | 2006-03-31 | 2011-01-11 | Biodesix, Inc. | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
| EP2539704A4 (en) * | 2010-02-24 | 2015-12-02 | Biodesix Inc | CANCER PATIENT SELECTION FOR ADMINISTRATION OF THERAPEUTIC AGENTS USING MASS SPECTROMETRY ANALYSIS |
| EP2668504A4 (en) | 2011-01-28 | 2015-06-10 | Biodesix Inc | PREDICTIVE TEST FOR SELECTING PATIENTS WITH METASTATIC BREAST CANCERS TO RECEIVE HORMONE THERAPY AND POLY THERAPY |
| EP2864792A1 (en) | 2012-06-26 | 2015-04-29 | Biodesix, Inc. | Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies |
| US8718996B2 (en) | 2012-07-05 | 2014-05-06 | Biodesix, Inc. | Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents |
| US10037874B2 (en) | 2014-12-03 | 2018-07-31 | Biodesix, Inc. | Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry |
| CN112710723B (zh) | 2015-07-13 | 2024-11-12 | 佰欧迪塞克斯公司 | 受益于pd-1抗体药物的肺癌患者的预测性测试和分类器开发方法 |
| WO2017136139A1 (en) | 2016-02-01 | 2017-08-10 | Biodesix, Inc. | Predictive test for melanoma patient benefit from interleukin-2 (il2) therapy |
| WO2017176423A1 (en) | 2016-04-08 | 2017-10-12 | Biodesix, Inc. | Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy |
| EP3566054A4 (en) | 2017-01-05 | 2020-12-09 | Biodesix, Inc. | PROCESS FOR IDENTIFYING CANCER PATIENTS LIKELY TO BENEFIT FROM IMMUNOTHERAPY FOR LASTING SUSTAINABLE SUB-GROUPS OF PATIENTS WHO HAVE A BAD PROGNOSIS GENERALLY |
| WO2019032525A1 (en) | 2017-08-07 | 2019-02-14 | Genecentric Therapeutics, Inc. | PROCESS FOR SUBTYPING EPIDERMOID CARCINOMA OF HEAD AND NECK |
| WO2019046585A1 (en) * | 2017-08-30 | 2019-03-07 | Genecentric Therapeutics, Inc. | ANALYSIS OF GENE EXPRESSION SUB-TYPES OF EPIDERMOID CARCINOMA OF HEAD AND NECK FOR TREATMENT MANAGEMENT |
| EP3773691A4 (en) | 2018-03-29 | 2022-06-15 | Biodesix, Inc. | Apparatus and method for identification of primary immune resistance in cancer patients |
| CN116685259A (zh) * | 2020-10-19 | 2023-09-01 | 本-古里安大学B.G.内盖夫技术和应用公司 | 尿细菌对抗生素的敏感性的快速直接鉴定和确定 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1540010B8 (en) | 2002-08-06 | 2010-07-14 | The Johns Hopkins University | Use of biomarkers for detecting ovarian cancer |
| CA2527321A1 (en) | 2003-05-30 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| US20050267689A1 (en) | 2003-07-07 | 2005-12-01 | Maxim Tsypin | Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications |
| US20050048547A1 (en) | 2003-07-17 | 2005-03-03 | Hongyu Zhao | Classification of disease states using mass spectrometry data |
| AU2005231101A1 (en) | 2004-03-30 | 2005-10-20 | Eastern Virginia Medical School | Lung cancer biomarkers |
| EP2439285B1 (en) * | 2004-03-31 | 2019-05-08 | The General Hospital Corporation | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| US20060029574A1 (en) | 2004-08-06 | 2006-02-09 | Board Of Regents, The University Of Texas System | Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity |
| US7908091B2 (en) | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| US7867775B2 (en) | 2006-03-31 | 2011-01-11 | Biodesix, Inc. | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
| US7736905B2 (en) * | 2006-03-31 | 2010-06-15 | Biodesix, Inc. | Method and system for determining whether a drug will be effective on a patient with a disease |
-
2009
- 2009-01-20 US US12/321,393 patent/US7867775B2/en active Active
- 2009-11-20 CA CA2718113A patent/CA2718113A1/en not_active Abandoned
- 2009-11-20 JP JP2010548752A patent/JP5025802B2/ja not_active Expired - Fee Related
- 2009-11-20 AU AU2009338174A patent/AU2009338174B2/en not_active Ceased
- 2009-11-20 WO PCT/US2009/006269 patent/WO2010085235A1/en not_active Ceased
- 2009-11-20 EP EP09774994A patent/EP2247954B1/en active Active
- 2009-11-20 KR KR1020107019382A patent/KR101131309B1/ko not_active Expired - Fee Related
- 2009-11-20 ES ES09774994T patent/ES2368784T3/es active Active
- 2009-11-20 AT AT09774994T patent/ATE516503T1/de not_active IP Right Cessation
- 2009-12-16 TW TW098143182A patent/TWI368737B/zh not_active IP Right Cessation
-
2011
- 2011-03-24 IL IL211943A patent/IL211943A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011513728A5 (enExample) | ||
| JP2012507033A5 (enExample) | ||
| Moisoiu et al. | SERS-based differential diagnosis between multiple solid malignancies: Breast, colorectal, lung, ovarian and oral cancer | |
| WO2011130938A1 (zh) | 一种人体血浆表面增强拉曼光谱结合主成分分析检测方法 | |
| JP5025802B2 (ja) | Ｅｇｆｒ経路を標的化する薬物による治療のための頭頸部癌患者の選択 | |
| JP2009534667A5 (enExample) | ||
| CN103954608B (zh) | 一种鉴定降糖中药中是否添加吡格列酮或罗格列酮的方法 | |
| Verdonck et al. | Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding | |
| JP2009538607A5 (enExample) | ||
| NZ719474A (en) | Method to use gene expression to determine likelihood of clinical outcome of renal cancer | |
| EP2977468A3 (en) | Methods of novel therapeutic candidate identification through gene expression analysis in pulmonary arterial hypertension | |
| WO2007109881A8 (en) | Biomarkers useful for diagnosing prostate cancer, and methods thereof | |
| Liu et al. | Label-free surface-enhanced Raman spectroscopy of serum based on multivariate statistical analysis for the diagnosis and staging of lung adenocarcinoma | |
| Feng et al. | Saliva analysis combining membrane protein purification with surface-enhanced Raman spectroscopy for nasopharyngeal cancer detection | |
| JP2015528110A5 (enExample) | ||
| Kang et al. | H-CNN combined with tissue Raman spectroscopy for cervical cancer detection | |
| TW201028687A (en) | Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway | |
| Marko-Varga et al. | Personalized medicine and proteomics: lessons from non-small cell lung cancer | |
| EP2707710A1 (en) | Diagnosis of cancer | |
| EA201400131A1 (ru) | Новый классификатор для молекулярной классификации миеломной болезни | |
| Radzol et al. | Optimization of Savitzky-Golay smoothing filter for salivary surface enhanced Raman spectra of non structural protein 1 | |
| CN116867911A (zh) | 用于胃癌预防和早期发现的生物标志物特征 | |
| GB2494580A (en) | Method for diagnosing lung cancer | |
| CN101936891A (zh) | 一种通过紫外光谱法鉴别不同香型白酒的方法 | |
| Liu et al. | Rapid discrimination of colon cancer cells with single base mutation in KRAS gene segment using laser tweezers Raman spectroscopy |